John Overdeck’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-336,164
| Closed | -$64.2K | – | 4154 |
|
|
2025
Q3 | $64.2K | Buy |
336,164
+113,837
| +51% | +$136K | ﹤0.01% | 3520 |
|
|
2025
Q2 | $378K | Sell |
222,327
-56,793
| -20% | -$95.8K | ﹤0.01% | 2703 |
|
|
2025
Q1 | $441K | Buy |
279,120
+67,916
| +32% | +$115K | ﹤0.01% | 2575 |
|
|
2024
Q4 | $378K | Buy |
+211,204
| New | +$673K | ﹤0.01% | 2660 |
|
|
2024
Q3 | – | Sell |
-10,313
| Closed | -$54.2K | – | 3167 |
|
|
2024
Q2 | $54.2K | Buy |
+10,313
| New | +$65.6K | ﹤0.01% | 2879 |
|
|
2023
Q4 | – | Sell |
-15,188
| Closed | -$46.9K | – | 3211 |
|
|
2023
Q3 | $46.9K | Sell |
15,188
-6,758
| -31% | -$19.5K | ﹤0.01% | 2823 |
|
|
2023
Q2 | $59.3K | Sell |
21,946
-27,316
| -55% | -$80.1K | ﹤0.01% | 2807 |
|
|
2023
Q1 | $146K | Sell |
49,262
-41,941
| -46% | -$123K | ﹤0.01% | 2616 |
|
|
2022
Q4 | $230K | Sell |
91,203
-256,555
| -74% | -$736K | ﹤0.01% | 2346 |
|
|
2022
Q3 | $633K | Buy |
347,758
+296,302
| +576% | +$781K | ﹤0.01% | 1664 |
|
|
2022
Q2 | $162K | Sell |
51,456
-66,984
| -57% | -$374K | ﹤0.01% | 2202 |
|
|
2022
Q1 | $732K | Buy |
118,440
+100,640
| +565% | +$885K | ﹤0.01% | 1840 |
|
|
2021
Q4 | $253K | Sell |
17,800
-484,606
| -96% | -$5.4M | ﹤0.01% | 3762 |
|
|
2021
Q3 | $4.02M | Buy |
502,406
+473,842
| +1,659% | +$7.53M | 0.01% | 1395 |
|
|
2021
Q2 | $816K | Buy |
28,564
+13,179
| +86% | +$383K | ﹤0.01% | 2662 |
|
|
2021
Q1 | $447K | Buy |
+15,385
| New | +$358K | ﹤0.01% | 3031 |
|
John Overdeck's EPIX Position: Q4 2025 in Review
John Overdeck sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 336,164 shares — an estimated $64.2K sold.
John Overdeck first reported a position in EPIX in Q1 2021 and held it in 16 quarters. The position peaked at $4.02M in Q3 2021. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- John Overdeck reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- John Overdeck sold 336,164 ESSA Pharma shares in Q4 2025, an estimated $64.2K.
- John Overdeck first reported a position in ESSA Pharma in Q1 2021 and held it in 16 quarters.
- John Overdeck's ESSA Pharma position peaked at $4.02M in Q3 2021.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.